Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2009
05/13/2009CN101432308A FAS binding antibodies
05/13/2009CN101432307A Cytotoxicity mediation of cells evidencing surface expression of CD44
05/13/2009CN101432306A Methods and compositions for targeting RELT
05/13/2009CN101432305A Transferrin receptor antibodies
05/13/2009CN101432304A Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
05/13/2009CN101432303A Methods for damaging cells using effector functions of anti-CDH3 antibodies
05/13/2009CN101432302A Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibod
05/13/2009CN101432301A Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
05/13/2009CN101432023A Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
05/13/2009CN101432022A Methods for damaging cells using effector functions of anti-epha4 antibodies
05/13/2009CN101432020A Methods and materials for the inhibition of transplant rejection
05/13/2009CN101432018A IL-13 binding agents
05/13/2009CN101429507A Heavy chain and light chain variable region gene of microcapsule algae toxin resistant monoclone antibody, and uses thereof
05/13/2009CN101429250A Mold toxin penicillic acid monoclone antibody and preparation method thereof
05/13/2009CN101429249A Anti-human chorionic gonadotrophin beta subunit monoclone antibody and preparation method thereof
05/13/2009CN101429248A Anti-double-chain DNA monoclone antibody with antineoplastic activity and preparation method thereof
05/13/2009CN101429247A Oriental schistosomiasis resistant natural numerator vaccine specific single-chain antibody
05/13/2009CN101429246A Method for producing immunoglobulins containing protection proteins and their use
05/13/2009CN101429244A Tetracycline and carrier protein couplet product, method for producing tetracycline antibiotic antibody uses thereof
05/13/2009CN101429243A Melamine and carrier protein couplet product, preparation method and uses of melamine antibody
05/13/2009CN101429242A Gentamicin and carrier protein couplet product, method for producing gentamicin antibody and uses thereof
05/13/2009CN101429241A Penicillin and carrier protein couplet product, method for producing beta-lactam penicillin antibody, and uses thereof
05/13/2009CN101429236A Type II non-structural protein 2B of dengue virus, recombinant expression vector, preparation and uses thereof
05/13/2009CN100486996C Antibodies to human MCP-1
05/13/2009CN100486995C Compositions and methods for WT1 specific immunotherapy
05/12/2009US7531896 Semiconductor device having a minimal via resistance created by applying a nitrogen plasma to a titanium via liner
05/12/2009US7531648 Gene therapy
05/12/2009US7531645 By ion exchange chromatography and involves changing the conductivity and/or pH of buffers in order to resolve the polypeptide of interest
05/12/2009US7531643 Detection human integrin associated protein
05/12/2009US7531642 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
05/12/2009US7531641 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
05/12/2009US7531640 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
05/12/2009US7531639 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
05/12/2009US7531638 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
05/12/2009US7531637 Produced by hybridomas; antipruritic agents; blocks scratching, dermatitis, or hairloss
05/12/2009US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation
05/12/2009US7531635 Monoclonal antibodies or functional fragment; immunoassay kit; female fertility diagnosis; Premature ovarian failure
05/12/2009US7531634 Bladder matrix protein peptides and methods of detection of bladder cancer
05/12/2009US7531633 Immunotherapy against infection; harvesting antibodies directed against Staphylococcus from blood of immunized subject for use as immunotherapeutic agents
05/12/2009US7531628 Canine CD20 compositions
05/12/2009US7531626 Tenebrio antifreeze proteins
05/12/2009US7531522 Polynucleotide with a sequence coding for a fusion protein that is an anti-fungal protein or peptide and an antibody FV fragment specifically recognising an epitope of an Ascomyceta, and a cellular targeting signal
05/12/2009US7531342 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
05/12/2009US7531322 Using tissue specific gene transfer element as tool in somatic gene therapy
05/12/2009US7531314 to produce anti-peptide antibodies, then radiolabeling the antibody, administering the radiolabeled antibody to the patient, detecting and quantifying the binding of the radiolabeled antibody to determine the extent of neurofibrillary tangles and amyloid plaques in the patient
05/12/2009US7531304 Method for screening FGFR-4 agonists
05/12/2009US7531179 Bipolymer conjugate comprising botulin-a peptide for use in conferring tolerance to clostridial toxin
05/12/2009US7531178 Immunoadhesin comprising a glycoprotein VI domain
05/12/2009US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules
05/12/2009US7531174 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; genetic engineering;
05/12/2009US7531171 Antibodies to non-functional P2X7 receptor
05/12/2009US7531170 Administering an antibody that specifically binds to OX40 ligand (OX4L) sufficient to reduce or inhibit a recall immune response associated with or that causes asthma
05/12/2009US7531169 or an antigen binding fragment comprising variable light chain region and heavy chain peptides, directed against isotypic determinants of immunoglobulin E (IgE), useful for diagnostics, prophylaxis and treatment of disease such as asthma, rhinitis, eczema, urticaria. dermatitis or food allergies
05/12/2009US7531168 Method for downmodulating immune response in type I diabetes
05/12/2009US7531166 IL-1β binding antibodies and fragments thereof
05/12/2009CA2284079C Immunotoxins and methods of inducing immune tolerance
05/12/2009CA2244195C Pin m iii gene in white pine
05/12/2009CA2109977C Giardia vaccines
05/07/2009WO2009058870A1 Compositions and methods for modulating immune responses
05/07/2009WO2009058812A1 Antibody purification by cation exchange chromatography
05/07/2009WO2009058797A1 Anti-hepcidin antibodies and uses thereof
05/07/2009WO2009058769A1 Purification of antibodies containing hydrophobic variants
05/07/2009WO2009058564A2 Immunosuppressive polypeptides and nucleic acids
05/07/2009WO2009058492A2 Fc variants with altered binding to fcrn
05/07/2009WO2009058346A1 Antibodies to gdf8 as uses thereof
05/07/2009WO2009058203A1 Radiolabeled monoclonal antibodies, methods of preparation using tcep, and uses thereof
05/07/2009WO2009057664A1 Antibody and use thereof
05/07/2009WO2009057437A1 Method of creating wheat variety and wheat product
05/07/2009WO2009056634A2 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)
05/07/2009WO2009056631A2 Molecules and methods for modulating complement component
05/07/2009WO2009056584A1 Anticomplement polypeptides of ixodes ricinus
05/07/2009WO2009056580A1 Rabbit monoclonal antibody (mab cv152) anti-indoleamine 2 3-dioxygenase (ido)
05/07/2009WO2009056509A1 Improved nogo-a binding molecules and pharmaceutical use thereof
05/07/2009WO2009056490A1 NEW ANTIBODIES SPECIFIC OF THE β-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS
05/07/2009WO2009056330A1 Soluble truncated apom proteins and medical uses thereof
05/07/2009WO2009056280A1 Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals
05/07/2009WO2009056268A1 An antigen associated with rheumatoid arthritis
05/07/2009WO2009055936A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibodies
05/07/2009WO2009036209A3 Homogeneous antibody populations
05/07/2009WO2009035420A8 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof
05/07/2009WO2009020645A3 Matriptase protein and uses thereof
05/07/2009WO2009007993A4 A process for purification of immunoglobulins using a pseudobioaffinity adsorbent
05/07/2009WO2008133873A3 Fgf-binding fusion proteins
05/07/2009WO2008112543A3 Rat, rabbit, and cynomolgus monkey il-21 and il-22 nucleotide and polypeptide sequences
05/07/2009WO2007061988A3 Methods for determining notch signaling and uses thereof
05/07/2009WO2007061936A3 Clearance of abnormal iga1 in iga1 deposition diseases
05/07/2009WO2007014162A3 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis
05/07/2009WO2006132809A3 Monoclonal antibody reagents
05/07/2009WO2006125202A3 Anti- mcp-1 antibodies, compositions, methods and uses
05/07/2009WO2006029398A3 All-trans-retinol : all-trans-13,14-dihydroretinol saturase and methods of its use
05/07/2009WO2005112999A3 Cancer treatment with inhibitors of collagen synthesis
05/07/2009US20090118486 Uspa1 and uspa2 antigens of moraxella catarrhalis
05/07/2009US20090118473 MN Gene and Protein
05/07/2009US20090118472 Biomarkers for toxic algae
05/07/2009US20090118219 Flea gaba receptor subunit nucleic acid molecules
05/07/2009US20090118217 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders
05/07/2009US20090118186 administering to a cancer patient a soluble tumor necrosis factor related apoptosis inducing ligand (TRAIL) polypeptide, selected from the extracellular domain of human TRAIL or fragment thereof, in the form of an oligomer; treatment of leukemia, melanoma or lymphoma
05/07/2009US20090118182 Fibroblast Growth Factor-Like Polypeptides
05/07/2009US20090118174 Novel peptides and methods for the treatment of inflammatory disorders
05/07/2009US20090118141 Methods of oligosaccharide profiling for the detection of ocular rosacea